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Abstract 
Cutaneous leishmaniasis is one form of leishmaniasis that chiefly infected the poor 
sections of the society. The prototypical therapeutic interventions in vogue are 
handicapped due to toxicity and an alarming increase in drug resistance. Furthermore, 
the absence of vaccines has raised the quest for alternative therapies. So, the aim of 
our study was to assess the anti-leishmanial activity of Euphorbia cactus Ehrenb, 
Euphorbia ammak Forssk, Euphorbia inarticulate Schweinf, and Pergularia 
tomentosa L. The extracts of plants were prepared by maceration method and by 
Soxhlet extractor. The extracts were dried and re-dissolved in 2% dimethyl sulfoxide 
(DMSO) 1% solvent.  Leishmania spp. cells were then tested with serial 
concentrations (15.6 μgml1 to 500 μgml1 ) of the extracts, using the 3-(4,5-
dimethylthazolk-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. All 
experiments were performed in triplicate and analyzed by ANOVA test. The optical 
density values as measured by Enzyme-Linked Immunosorbent Assay (ELISA) were 
used to calculate the IC50 values.  The results indicated that the methanolic latex 
extract of Euphorbia cactus Ehrenb, Euphorbia ammak Forssk had potent anti-
leishmanial activity against the promastigotes of Leishmania spp. based on a dose-
dependent response analysis. The IC50 values for Euphorbia cactus Ehrenb and 
Euphorbia ammak Forssk after 24h incubation against Leishmania spp. promastigotes 
were less than <15.6 μgml-1. Furthermore, the phytochemical analysis of methanolic 
extract showed the presence of alkaloids, phytosterols, phenols, saponins, and 
flavonoids in which these components have been proven previously to be the active 
compounds against Leishmania parasite. In conclusion, the present study reveals that 
latex extract of Euphorbia cactus Ehrenb and Euphorbia ammak Forssk contain active 
compounds that have anti-leishmanial activity, which could serve as an alternative 
agent in the treatment of cutaneous leishmaniasis, but further studies would, therefore, 
be needed to assess the activity of these materials of this plants in vivo clinical 
response and study their toxicity on cell lines.  
Keywords: anti-leishmanial activity, Euphorbia cactus Ehrenb, Euphorbia ammak 
Forssk, Euphorbia inarticulate Schweinf, Pergularia tomentosa L, Yemeni Medicinal 
Plants. 
 
 
Introduction  
Cutaneous leishmaniasis (CL), one clinical form of leishmaniasis, a term referred to 
skin clinical symptoms caused by several species of obligate intra-monocular 
phagocytic cells protozoan parasites produce a skin ulcer that heals spontaneously in 
most cases leaving an unsightly scar . These parasites belong to the genus 
Leishmania,  that transmitted by the bite of a female phlebotomine sand fly.
1-4
 
Cutaneous leishmaniasis is still one of the world’s most neglected disease that 
significant morbidity worldwide and shows a worrying increasing trend. CL is 
endemic in large areas of the tropics, subtropics, and the Mediterranean basin.
5
 In 
Yemen, this disease is endemic and the most prevalent skin infectious diseases.
6,7
  To 
date progression in developing an effective vaccine against CL has not been successes 
  
and chemotherapy is the only effective way to treat the disease. However, current 
therapy is toxic, expensive, have severe side effects, as well as it emerges a resistance 
to drugs. Therefore, there is a great and urgent need for developing a new and safe 
anti-leishmanial drug.
8-11
  
Investigation bioactive compounds from plants that used medicinally are regarded as 
one of the strategies to discover new drugs for leishmaniasis.
12
  The World Health 
Organization (WHO) has estimated that approximately 80% of individuals rely on 
traditional medicines for their primary health care needs.
13,14
  In different cultures and 
countries, many plants are used in the form of powders, crude extracts or infusion to 
treat several diseases including parasitic diseases without any scientific evidence of 
efficacy. In Yemen, there is a rich tradition of the use of herbal medicine for the 
treatment of various diseases, including inflammations, infections and other 
diseases.
15-18
  
Despite the worldwide spread of Cutaneous leishmaniasis and the significant 
morbidity that caused by this disease in the world as well as in Yemen, its current 
drugs have limitations. So the investigation of plants that are used in folk medicine 
may have prognostic value to discover new and safe cutaneous leishmanicidal drug. 
The present study conducted to offer a scientific basis for the traditional use of 
Euphorbia cactus Ehrenb, Euphorbia ammak Forssk, Euphorbia inarticulate 
Schweinf, stems and leaves of Pergularia tomentosa L as cutaneous leishmanicidal, 
this may be regarded as future promising phytotherapeutics in the treatment cutaneous 
leishmaniasis. The objectives of this study were to evaluate the in vitro cutaneous 
anti-leishmanial activity of Euphorbia cactus Ehrenb, Euphorbia ammak Forssk, 
Euphorbia inarticulate Schweinf, stems and leaves of Pergularia tomentosa L 
extracts.Also carrying out preliminary phytochemical screening of those plant 
extracts.  
Subjects and Methods 
Plant materials 
Four selected plants (Euphorbia cactus Ehrenb, Euphorbia ammak  Forssk, Euphorbia 
inarticulate  Schweinf, stem and leaf of Pergularia tomentosa L (table 1) commonly 
used in Yemen by traditional healers   for the treatment of cutaneous leishmaniasis  and 
other skin diseases  were collected  from  Taiz governorate of Yemen in September 
2016, and botanical identification was by Dr. Hassan Ibrahim botanist at the Botany 
section, Biology department, Faculty of Science,  Sana
'
a university, Sana'a (Yemen).  
Plant preparation 
Stems and leaves of Pergularia  tomentosa L and phylloclade of Euphorbia inarticulate  
Schweinf were collected, washed, sliced, weighed and sundried under the shade at room 
temperature.  After complete drying , they grinded to a coarse powder  in electrical 
blender.  The dried crude plants were maintained in dark vials  and stored at  -20 °C until 
used.
19,20
  The latex of Euphorbia cactus Ehrenb  and  Euphorbia ammak  Forssk were 
collected in clean glass bottles and were kept in the refrigerator (4°C – 8°C)  until 
extraction.
20
 
Plants extraction:  
The dried plants were extracted successively with MeOH (80%) by using a Soxhlet 
apparatus.  The obtained extracts were filtered through a Whatman-1 filter paper. The 
filtrates were dried by evaporation on a rotary evaporator below 45˚C and freeze dryer to 
give the crude dried extract.  All extracts were stored at  -20 
o
C  until used, the yield 
obtained are shown in Table 2. 
            Latex were extracted by maceration using MeOH(80%). The latex were soaked 
(1 ml) in 10 ml of solvent in a stoppered container with frequent agitation at room 
  
temperature. After maceration the soaked latex were filtrated through a Whatman-1 filter 
paper. The filtration were dried by a rotary  evaporation and freeze drier to give the 
crude dried extract. The  crude dried extract of latex  were stored at – 20, the yield 
obtained are shown in Table 2. 
Anti-promastigote assay 
Patient selection and  Leishmania spp. isolation: 
 Following clinical diagnosis by dermatologist, and confirmed by laboratory. 
Leishmania spp.  were isolated from the patient with cutaneous leishmaniasis 
infection. Skin lesions of the patients were cleansed with 70% ethanol before sample 
scraping. These preparations were stained with Giemsa and examined under a light 
microscope with magnification (×1000),  and it was inoculated in Nicolle-Novy-
McNeal (NNN) culture medium. The culture tubes were kept in an incubator at 25
0
C 
for 5-10 days. Leishmania spp.  promastigote  that observed during microscopy  
transferred to RPMI-1640  and incubated at 25 °C for mass cultivation medium. 
Patient who  included in this study were : (1) patient with infection not exceed 6 
months, (2) patient  did not used drugs or herbs, (3) Heavy infection . 
Determination of 50% promastigote growth inhibitory concentration (IC50) of 
the plant extracts  
 Stock solution of crude extracts was prepared in 2 % (DMSO)/Deionized water at 10 
mg/10mL.  RPMI-1640 medium were distributed in each well of a 96 well  plate. The 
extract solutions  (100µl) were serially diluted  down each lane of 96-well plate with 
medium. Then, the growing cells at 10
6
 promastigotes/ml  were added to each well to 
give final six concentration of plant extracts 15.6µgml
-1
, 31.25 µgml
-1
, 62.56 µgml
-1
, 
125 µgml
-1
, 250 µgml
-1
, 500 µgml
-1 (
two folds dilutions). The final concentration of 
DMSO was not be higher than 1% (v/v)  as this concentration did not affect the 
parasite growth rate, mobility, morphology
21
  in all experiments. A Pentostam (Albert 
David Limited-India) was used   as positive control at 10µgml
-1
, untreated media were 
used as negative control, and DMSO alone was used as solvent control.  96-well 
micro-plates were incubated at 26
0
C.  After the incubation,  the effect of the isolated 
extracts on cell viability was assessed using the 3-(4,5-dimethylthazolk-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) assay, which measures the metabolic activity of 
mitochondria.
22
   In which, 20μL of MTT  solution (5mgmL-1)  (SIGMA) was added 
to each well and incubated at 26∘C for 4 h at 26 ˚C. The test principle "Tetrazolium 
salts are cleaved to formazan dye by cellular enzyme mitochondrial succinate 
dehydrogenase (only in the viable promastigites)" . Finally,  the MTT solubilization 
solution   was added to each well to dissolve the insoluble purple formazan product 
into coloration solution  and  incubated for another 10 min. The absorbance was 
measured at 570 nm for each well,  using an ELISA reader.
23,24
 The live 
promastigotes percentage inhibition ratio were calculated as described by Bansal et 
al..
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Inhibition Rate (I%):  
Data were presented as mean±SD  of  triplicate experiments for each well.  Mediam 
inhibitory concentration value (IC50 value), the concentration that decreased parasite 
growth by 50% was calculated using linear regression analysis  (dose – response  
analysis) associated with 95% confidence interval. Lower IC50 value indicates greater 
anti-leishmanial activity. 
Leishmania spp. counting 
 20 µl of cells from the culture were taken and placed in 1.5 ml Eppendorf tube 
containing 20 µl of Eosin (1%) then mixed. After that 10µl of cells were placed on  
  
haemocytometer (Thoma slide).  5 squares were counted then the result number were 
multiply by 100000 so we can get the number of cells in 1 ml of culture . 
Preliminary Qualitative Phytochemical Screening  
 The dried extracts were tested to identify  alkaloids, carbohydrates, glycosides, fixed 
oil and fats, anthraquinones, phenolic compounds and tannins, phytosterols, proteins, 
saponins, gum and mucilage. A preliminary phytochemical analysis was carried out 
using tube-test reaction and thin-layer chromatography (TLC) as described by Banu 
and Cathrine.
19
 
Statistical Analysis 
 Data are presented as mean ± SD of triplicate experiments , and the plant extract  
concentration required for 50% inhibition in vitro (IC50) calculated  by dose-response  
analysis associated with 95% confidence interval by Graph pad prism 7 Demo. 
Ethical Consideration 
Ethical clearance for the study was taken from the Faculty of Medicine and Health 
Sciences Research Review Committee. Informed Consent was taken from the patients 
before the collecting specimens. 
RESULTS 
The percentages of extraction yield for each  investigated plant were summarized in 
Table 2. The results of anti-Promastigote assay (in vitro test) for the five  plant 
extracts against promastigotes stages  of  Leishmania spp. are summarized in Table 
3,4, 5, 6,7. Data in Table 8  elucidate  that the highest antileishmanial activity was 
obtained from Euphorbia cactus Ehrenb and Euphorbia ammak Forssk  with IC50 
value < 15.6 µgml
-1. 
The leaves and stems  of Pergularia tomentosa L  and Euphorbia 
innerticulata  Schweinf extracts showed  inactive antileishmanial activity (IC50 value 
> 500 µgml
-1
). 
Phytochemical analysis and thin layer chromatography results 
  Phytochemical analysis of extracts indicated the presence  of various bioactive 
components. Compounds, such as alkaloids were found in the five plant extracts. 
However, fixed oils, fats and Anthraquinones were absent  in all extracts,  
Phytosterols were found in the four plant extract and  in Euphorbia ammak Forssk 
extract was absent.  Glycosides, Gum and Mucilage were found only  in Euphorbia 
cactus  Ehrenb and Euphorbia ammak Forssk,  Protins were found only in Euphorbia 
cactus Ehrenb and Euphorbia inarticulate Schweinf. However, Saponines  were 
found only in Euphorbia cactus Ehernb, Euphorbia ammak Forssk, stem and leaf  of 
Pergularia tomentosa L, and carbohydrates were found in Euphorbia inerticulata 
schweinf, stem and leaf of Pregularia tomentosa L (Table 9) . The TLC analysis 
showed spots of determined constitutes  in each extract (Table 10). 
Discussion 
      The first choice drug for treatment of cutaneous leshmaniasis  is Pentostam which 
has toxic side effects. Also, no  vaccine is available to cure this disease.  Most of the 
studies directed towards plants that is used traditionally as potential source of new 
alternative medicines. Some of the drugs obtained from plants used in the treatment of 
diseases caused by protozoan include alkaloids quinine obtained from the plant genus  
Cinchora and  artemisinin  obtained from  the plant genus Artemisia  annua and  both 
of  them used in the treatment of malaria.  As well as, emetin obtained from the plant 
genus Cephaelis used in treatment of ameobiasis.
26
  Our findings showed that the 
methanol latex extract of Euophobia cactus  Ehrenb (Euophrbiaceae) had choice 
antileshmanial activity (IC50<15.6 µgml
-1
 against promastigotes).  There was no 
  
previous studies reported about its biological activities  against Leishmania spp. to 
compare with, so our results appear to be  one of the first that studied its activity.  The 
methanol latex extract of Euphorbia ammak Forssk showed a good antileishmanial 
activity (IC50<15.6µgml
-1 
against promastigotes). Our data is compatible with data  
reported by  Abdel-Sattar et al. (2010) against Leishmania infantum which found to 
inhibit the growth of  Leishmania infantum with IC50 value < 24.05 µgml
-1
.
27
 These 
findings confirmed that latex of Euophobia cactus  Ehrenb and Euphorbia ammak 
Forssk could be considered as having promising antileishmanial activity.  
      The methanol extract of Euphorbia inarticulate   Schweinf  phylloclades showed 
no antileishmanial activity (IC50>500 µgml
-1
 ).  Although, there was no previous 
studies reported about its biological activities  against  Leishmania spp.  to compare 
with, so our results appear to be  one of the first that study its antileishmanial activity. 
        The leaves and stems  extracts of  Pergularia tomentosa L and Euphorbia 
inarticulate  Schweinf showed no antileshmanial activity (IC50>500 µgml
-1
 ), while 
several studies reported good activity of these plants against fungi.
28,29
 
Flavnoids may be the active compound in Euphorbia ammak Forssk against 
Leishmania spp. in our study. Our findings can be confirmed by the finding of Das et 
al.
30
 in which they tested  the antileishmanial activity of flavonoids  against 
topoisomerase I of Leishmania donovani. They illustrated that these compounds 
inhibited topoisomerase I which subsequently inhibit the relegation step in parasite 
growth.
30
 
      Phenolic, saponins, and alkaloids that we detected in our study may be they  are  
the active compounds responsible for antileishmanial activity in Euphorbia ammak 
Forssk and Eiphorbia cactus Ehrenb.   Kayser et al.
31
  in their comprehensive review 
of antiparasitic drug development view  phenolic, saponins, and alkaloids  have 
inhibition activity against Leishmania parasite.
31, 32
 
        Phytochemical results of leaves and stems of Pergularia tomentosa L indicated 
the presence of saponins, phytosterols, phenolic compounds, tannins, carbohydrates, 
alkaloids, and flavonoids, except coumarins only present in stems. The phytochemical 
results of leaves and stems of Pergularia tomentosa L in our study is in agreement 
with  Hassan et al. (2007) and Shinkafi (2014) in Nigeria, except glycosides, and 
anthraquainins were not present in our extracts  of Pergularia tomentosa L.
28, 29
  The 
absent of glycosides, and anthraquainins in our plant Pergularia tomentosa L might 
be due to the environmental factors, such as altitude, temperature, illumination, 
precipitation, humidity, soils and locations as described by Zidorn and Stuppner 
(2001) in which they referred these differences in components is due  to the 
environmental factors.
33
   
Conclusion 
          In conclusion, the methanolic extract of  Euphorbia cactus Ehrenb and 
Euphorbia ammak Forssk  showed a good antileishmanial activity with IC50 
value>15.6 µgml
-1
 relative to negative control. The preliminary phytochemical 
investigation reveal the extracts contain secondary metabolites, that indicate these 
plants may be highly promising candidate drugs. Furthermore the results offer a 
scientific basis for the traditional use of investigated plants.  This is a preliminary 
evaluation using promastigotes must be complemented with an evaluation using 
intracellular amastigotes in macrophages. At the same time, an evaluation of the 
possible cytotoxicity of the tested plants is important. Further screening for Yemeni 
plants species, especially that are used in traditional medicine must be done for 
searching of potential anti-leishmanial active constituents and record ethno-botanical 
data.   
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   Table  1: List of the selected plants that used in the investigation 
  
Plant species (family) Local  name 
Plant part 
used 
a
 
Site of collection 
Euphorbia cactus Ehrenb 
(Euphorbiaceae) 
ثركا ,يثرك ,ثرك , لاص ,
قبشع ,حلق ,قمع  
Lat. North Taiz 
Euphorbia ammak Forssk 
(Euphorbiaceae) 
هقمع ,قمع  Lat. North Taiz 
Euphorbia inarticulate 
Schweinf 
(Euphorbiaceae) 
يصق ,صصقا ,صاصق ,بيص ,
حلك ,طاحم ,شيرخ  
Pha. North Taiz 
Pergularia tomentosa L 
(Asclepiadeceae) 
هقلغ ,قلغ ,شيباك ,ةيماد  S,L North Taiz 
 
   a- S. :Stem,  Pha. : phylloclades,  L:Leaves ,  Lat.: Latex. 
 
Table 2: Percentage  extraction yield of plant extracts.   
No. Plant name Crude 
methanolic 
extract (g) 
Amount of plant extracted(g) and  
yield  of extraction(%) 
1 Euphorbia cactus Ehrenb 
5.24 
206  (2.54%) 
2 Euphorbia ammak Forssk  
11.215 
309 (3.629%) 
3 Euphorbia inarticulate  Schweinf  
32.870 
350 (9.39%) 
4 Pergularia tomentosa L leaves  
29 
300 (9%) 
5 Pergularia tomentosa L Stems  
43.98 
300 (14.66%) 
Unit of latex express as g. 
Table 3: In vitro l activity of Euphorbia cactus Ehrenb methanolic extracts on  Leishmania 
spp.   after  24h 
Concentration Parasite inhibition  
mean±SD* 
Inhibition% 
15.6µg/ml 040.0±040.. a,b 5040 
31.25µg/ml 040.0±0.0.. a,b 5040 
62.56µg/ml 040.0±040.0 a,b 5.4.. 
125µg/ml 040.5±0400. a,b 0.4.0 
250µg/ml 040.00±04000 a,b 0.40. 
500µg/ml 040.0±0400. a,b 0.400 
Untreated control 632.0±63660   
 Mean ±SD is OD values of 3 wells. * Average ± standard division, 
a
 No significant 
difference compared to each other (P>0.05). 
b
 Significant difference compared to untreated 
wells (P<0.05) 
Table 4: In vitro activity of Euphorbia ammak Forssk  methanolic extracts against  
Leishmania spp. after 24h. 
  
Concentration Parasite inhibition (mean±SD*) Inhibition% 
15.6µg/ml 0.088±0.006
b
 62.71 
31.25µg/ml 0.089±0.004
b
 62.28 
62.5µg/ml 0.084±0.002
b
 64.4 
125µg/ml 0.075±0.001
b,c
 68.22 
250µg/ml 0.067±0.007
b,c
 71.61 
5006µg/ml 0.068±0.001
b,c
 71.18 
Untreated control 632.0±63660   
Mean ±SD is OD values of 3 wells. * Average ± standard division,  
b
 Significant difference 
compared to untreated wells (P<0.05). 
c
 significant difference compared to 15.6, 31.25, and 
62.5µg/ml  (P<0.05). 
Table 5: In vitro activity of Euphorbia inerticulata Shweinf extracts against  Leishmania 
spp. for 24h 
Concentration Parasite inhibition (mean±SD*) Inhibition% 
15.6µg/ml 0.164±0.033
b
 30.5 
31.25µg/ml 0.155±0.016
b
 34.32 
62.56µg/ml 0.154±0.015
b
 34.74 
125µg/ml 0.142±0.012
b
 39.83 
250µg/ml 0.141±0.01
b
 40.25 
500µg/ml 0.119±0.008
b,c
 49.59 
Mean ±SD is OD values of 3 wells. * Average ± standard division, 
b
 Significant difference 
compared to untreated wells (P<0.05). 
c
 significant difference compared to 15.6µg/ml  
(P<0.05). 
 
Table 6: In vitro activity of Pergularia tomentosa L. leaves methanolic extracts against  
Leishmania spp. for 24h. 
Concentration Parasite inhibition (mean±SD*) Inhibition% 
15.6µg/ml 0.172±0.03
a,b
 27.11 
31.25µg/ml 0.168±0.022
a,b
 28.81 
62.56µg/ml 0.155±0.021
a,b
 34.32 
125µg/ml 0.151±0.001
a,b
 36.01 
250µg/ml 0.146±0.021
a,b
 38.13 
500µg/ml 0.146±0.033
a,b
 38.13 
Untreated control 632.0±63660  
Mean ±SD is OD values of 3 wells. * Average ± standard division,  
a
 No significant 
difference compared to each other (P>0.05). the 
b
 Significant difference compared to 
untreated wells (P<0.05) 
  
Table 7: In vitro activity of Pergularia tomentosa L. stems methanolic extracts against  
Leishmania spp. for 24h 
Concentration Parasite inhibition (mean±SD)* Inhibition% 
15.6µg/ml 04.00±0400.  ..4.5 
31.25µg/ml 04.0.±0400.  ..405 
62.5µg/ml 04.50±04005 b,c .040. 
125µg/ml 04.0.±0400. b,c .0400 
250µg/ml 04.0.±0400. b,c .040. 
5006µg/ml 04.0.±040.. b,c .040. 
Untreated control 04..0±04005   
Mean ±SD is OD values of 3 wells. * Average ± standard division,  
b
 Significant difference 
compared to untreated wells (P<0.05). c significant difference compared to 15.6 and 31.25 
µg/ml  (P<0.05). 
 
Table 8: IC50 values(µg/ml) for promastigotes growth inhibition of the methanol extracts 
of  five plant. 
Plant extracts IC50µg/ml 
Euphorbia cactus Ehrenb <15.6 
Euphorbia ammak <15.6 
Euphorbia innerticulata  Schweinf >500 
Pergularia tomentosa L. L >500 
Pergularia tomentosa L. S >500 
IC50=Inhibitory concentration 50%, L= leaves, S= stems. 
Table 9:  Qualitative phytochemical analysis of  plant extracts by chemical method. 
Constituents Test E.C E.A E.I P.L P.S 
Alkaloids 
Mayer’s test + + + + + 
Wanger’s test + + + + + 
Carbohydrates Bendict’s test - - + + + 
Fixed oil & fats Spot test - - - - - 
Glycosides Salkowski’s test + + - - - 
Anthraquinones Borntrager’s test - - - - - 
Phenolic 
compounds & 
Tanins 
Ferric chloride test - - + + + 
Mg  and HCL reduction 
test 
- - + + + 
Phytosterols 
Libermann-Burchard’s 
test 
+ - + + + 
Proteins Biuret test + - + - - 
Saponins Foam test + + - + - 
Gum andMucilage Gum and Mucilage test + + - - - 
+= signify presence , -= signify Absence,  E.C= Euphorbia cactus, E.I= Euphorbia inerticulata, E.A= 
Euphorbia ammak,  P.L= Pergularia tomentoa L leaves, P.S= Pergularia tomentoa L stems 
  
Table 10:  TLC investigation of methanol extract of five plant extracts. 
 
No. Constituent Solvent System Plant extract No. spots Rf values 
 
 
1 
Anthraglycoside EtoAc:MeOH:water 
(100:13.5:10) 
E.C -- -- 
E.A -- -- 
E.I 1 0.62 
PL 1 0.58 
PS 3 0.2 
0.42 
0.56 
 
 
2 
 
Bitter principles 
EtoAc:MeOH:water 
(100:13.5:10) 
E.C 2 0.05 
0.69 
E.A 2 0.072 
0.73 
E.I 2 0,53 
0.8 
PL -- -- 
PS 3 0.29 
0.56 
0.87 
 
 
3 
Flavonoid  
EtOAc:formica.:glacial 
acetica.:water(100:11:11:26) 
E.C -- -- 
E.A 1 0.68 
E.I 2 0.6 
0.72 
PL 1 0.52 
PS 1 0.52 
 
 
4 
Saponins CHCL3:glacial acetic a.: 
MeOH:water(64:32:12:8) 
E.C 1 0.14 
E.A 1 0.14 
E.I 1 0.5 
PL 2 0.12 
0.46 
PS 2 
 
 
0.3 
0.4 
 
 
5 
Coumarins Diethyl ether:toluene (1:1) E.C 1 
 
0.59 
E.A 1 0.70 
E.I -- --- 
PL -- --- 
PS 3 0.14 
0.63 
0.73 
TLC: thin layer chromatography, EtoAc: ethyle acetate, MeOH: methanol, CHCL3:chloroform, a: acid, RF:   retention 
factor,---:absent, EC:Euphorbia cactus Ehrenb, EA:Euphorbia ammak, EI=Euphorbia inerticulata shwenf , PL:pergularia 
tomentosa  L.leaves,, PS:Pergularia tomentosa L.  stem 
TLC: (a)  anth (anthraquinones) after sprayed  with 10%ethanolic KOH agent, (b) BIT(bitter principles) after sprayed with 
vanillin sulpharic acid, (c) Fl(flavonoids) after sprayed with polythlene glycol, (d)  saponins   after sprayed with vanillin 
supharic acid ), and(e)   coumarins after sprayed with 10 % ethanolic KOH. Abbreviations at the end of plates  in each 
plateare:PL, Pergularia tomentosa L leaves, PS: Pergularia tomentosa L stems, EA: Euphorbia ammak, EI: Euphorbia 
inerticulta, EC:Euphorbia cactus  
